188 related articles for article (PubMed ID: 28339094)
1. F221Y mutation in hepatitis B virus reverse transcriptase is associated with hepatocellular carcinoma prognosis following liver resection.
Li H; Jia J; Wang M; Wang H; Gu X; Fang M; Gao C
Mol Med Rep; 2017 May; 15(5):3292-3300. PubMed ID: 28339094
[TBL] [Abstract][Full Text] [Related]
2. Precore/Core Region Mutations in Hepatitis B Virus DNA Predict Postoperative Survival in Hepatocellular Carcinoma.
Xie Y; Liu S; Zhao Y; Zhang L; Zhao Y; Liu B; Guo Z
PLoS One; 2015; 10(7):e0133393. PubMed ID: 26208136
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
4. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-naïve Korean patients infected with genotype C2.
Kim JE; Lee SY; Kim H; Kim KJ; Choe WH; Kim BJ
World J Gastroenterol; 2017 Jun; 23(23):4222-4232. PubMed ID: 28694662
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma.
Yeh CT; So M; Ng J; Yang HW; Chang ML; Lai MW; Chen TC; Lin CY; Yeh TS; Lee WC
Hepatology; 2010 Dec; 52(6):1922-33. PubMed ID: 20814897
[TBL] [Abstract][Full Text] [Related]
9. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
11. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
12. Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.
Mathews P; Lee D; Chung YH; Kim JA; Lee JH; Jin YJ; Park W; Lyu H; Jaffee E; Zheng L; Yu E; Lee YJ
Ann Surg Oncol; 2013 Apr; 20(4):1216-22. PubMed ID: 23104706
[TBL] [Abstract][Full Text] [Related]
13. Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Higaki I; Takemura S; Yamamoto T; Nishiguchi S; Kinoshita H
Dig Surg; 2001; 18(1):26-33. PubMed ID: 11244256
[TBL] [Abstract][Full Text] [Related]
14. Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma.
Wu Y; Gan Y; Gao F; Zhao Z; Jin Y; Zhu Y; Sun Z; Wu H; Chen T; Wang J; Sun Y; Fan C; Xiang Y; Qian G; Groopman JD; Gu J; Tu H
PLoS One; 2014; 9(5):e94864. PubMed ID: 24788140
[TBL] [Abstract][Full Text] [Related]
15. Profiles of mutations in hepatitis B virus surface and polymerase genes isolated from treatment-naïve Nigerians infected with genotype E.
Olusola BA; Faneye AO; Oluwasemowo OO; Motayo BO; Adebayo S; Oludiran-Ayoade AE; Aleru B; George UE; Oragwa AO
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33704041
[No Abstract] [Full Text] [Related]
16. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
18. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma.
Zhang AY; Lai CL; Poon RT; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
J Gastroenterol Hepatol; 2016 Sep; 31(9):1638-45. PubMed ID: 26905957
[TBL] [Abstract][Full Text] [Related]
20. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
